Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionProfunds - Profund Vp Ultrasmall-cap
Latest Disclosed Ownership387 shares
Latest Disclosed Value $ 9,582
Profunds - Profund Vp Ultrasmall-cap reports 1.53% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On May 20, 2026 - Profunds - Profund Vp Ultrasmall-cap filed a NPORT-P form disclosing ownership of 387 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $9,582 USD as of March 31, 2026. The entity filed a previous NPORT-P on February 19, 2026 disclosing 393 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -1.53% during the quarter. The current value of the position is $12,187 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-20 2026-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 387 -6 -1.53 10 0.00 0.0626
2026-02-19 2025-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 393 -7 -1.75 9 28.57 0.0613
2025-11-26 2025-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 400 -4 -0.99 8 -12.50 0.0527
2025-08-26 2025-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 404 -4 -0.98 9 -11.11 0.0673
2025-05-28 2025-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 408 -22 -5.12 10 12.50 0.0865
2025-02-27 2024-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 430 -45 -9.47 9 -11.11 0.0582
2024-10-31 2024-09-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 475 31 6.98 9 50.00 0.0575
2024-08-27 2024-06-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 444 -48 -9.76 7 -14.29 0.0528
2024-05-28 2024-03-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 492 27 5.81 8 0.00 0.0463
2024-02-27 2023-12-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 465 46 10.98 8 75.00 0.0462
2023-11-28 2023-09-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 419 15 3.71 5 -20.00 0.0406
2023-08-28 2023-06-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 404 -3 -0.74 5 -16.67 0.0399
2023-05-25 2023-03-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 407 -9 -2.16 7 -14.29 0.0527
2023-02-27 2022-12-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 416 21 5.32 8 40.00 0.0617
2022-11-28 2022-09-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 395 47 13.51 5 150.00 0.0437
2022-08-26 2022-06-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 348 -140 -28.69 2 -50.00 0.0192
2022-05-25 2022-03-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 488 -4 -0.81 4 33.33 0.0187
2022-02-25 2021-12-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 492 25 5.35 3 50.00 0.0117
2021-11-26 2021-09-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 467 -11 -2.30 2 0.00 0.0083
2021-08-27 2021-06-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 478 -20 -4.02 3 0.00 0.0076
2021-05-26 2021-03-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 498 170 51.83 2 100.00 0.0078
2021-02-26 2020-12-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 328 -5 -1.50 1 -50.00 0.0050
2020-11-20 2020-09-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 333 45 15.62 1 -100.00 0.0075
2020-08-26 2020-06-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 288 288 1 0.0110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.